Molina’s third-quarter adjusted earnings per share exceeded Bernstein’s expectations but fell by more than half year over year. Preliminary renewal rates for 2027 have improved and could ease pressure from medical costs; membership losses and delays to new contracts, however, weigh on the revenue outlook.
Corning’s third-quarter revenue and earnings per share both exceeded expectations, with optical communications the main contributor, but free cash flow fell short. The company’s fourth-quarter revenue guidance was below Bernstein’s forecast, while its earnings-per-share guidance was higher.
Coca-Cola raised its 2026 guidance, and Bernstein sees little execution risk remaining this year. But once the volume boost from the World Cup enters the comparison base, price and mix will need to improve to sustain growth in 2027.
Third-quarter revenue and earnings per share both beat expectations. Bernstein believes the scale of the OpenAI project deployment could bring greater growth, but the company's 2027 margin guidance is below the firm's forecast, and capacity expansion is expected to turn free cash flow negative.
Improved vehicle utilization in one-way truckload transportation drove revenue per truck up approximately 34% year over year in the third quarter; however, fuel, driver and insurance costs eroded profits, and Goldman Sachs again cut its fourth-quarter earnings-per-share forecast.
WuXi AppTec’s new orders and early-stage R&D demand are improving; TrendForce expects memory price increases to continue through the first half of 2028. Japanese bank valuations have fallen, while deposit competition at HSBC is weighing on net interest income expectations.
Hard-drive capacity shipments and prices both rose, and Seagate’s guidance for the next quarter was well above market expectations. Potential industry capacity expansion and lower peer valuations, however, also constrain the stock’s valuation.
Revenue and operating margin both exceeded market expectations, but ratings growth fell short of Goldman Sachs’ forecast; the raised full-year revenue guidance remains below the previous market consensus.
Johnson & Johnson management expects operational sales growth to accelerate in 2027 and says the medical devices business had rebounded in October. Longer-term growth depends on new product launches and pipeline progress, particularly expansion into solid tumors.
Mo-rez achieved a confirmed response rate of 62% in platinum-resistant ovarian cancer, while global data for Ris-rez in small-cell lung cancer were also close to those from a Chinese study. Goldman Sachs sees both assets as competitive, but higher doses were associated with more serious adverse events, and the near-term focus remains oncology drug commercialization.
Earlier concentrate shipments helped Coca-Cola beat third-quarter revenue and profit expectations, and the company raised its full-year earnings per share guidance. Goldman Sachs is positive on operating momentum but believes next year's asset sale, currency pressures and higher valuation limit the stock's appeal.
Based on the size of an earlier deal, HSBC estimates that the new financing could support approximately 1.7 to 1.8 GW of computing capacity deployment. Against Broadcom management’s target of deploying 5 GW in 2027, the question of whether further similar financing will be needed has come into focus.
HSBC expects Apple’s revenue for the quarter ended September 2026 to rise 10.6% year on year, slowing from the previous quarter. Early sales of the iPhone 18 Pro and preorders for the foldable Duo have been positive, but the Duo’s inner-screen issues and chip costs warrant attention.
Higher server memory and enterprise SSD prices drove SK hynix’s third-quarter revenue and operating profit to quarterly records, but foreign-exchange and investment valuation losses left net profit below expectations. The company also announced a large shareholder return plan and expects memory shipments to accelerate in the fourth quarter.
Besi has received cumulative demand for more than 215 hybrid bonding tools from 23 customers. Adoption in logic-chip mass production is progressing faster, while HBM orders remain focused on research and development and pre-production preparations. JPMorgan maintains its Overweight rating and is watching the timing of technology adoption.
Infant formula revenue grew in the third quarter and channel inventories remained low. Swisse also beat Morgan Stanley’s expectations after excluding shipments brought forward, but a decline in the China pet nutrition business, cost pressures and a high comparison base next year continue to constrain growth.
Higher copper, gold and plastic prices weighed on third-quarter gross margin, but the transition to new CPU platforms could give Lotes an opportunity to pass on costs. Morgan Stanley upgraded the stock and expects AI products to contribute more rapidly in 2027.
In the week ended 23 October, North American internet stocks as a whole underperformed the broader market, with particularly sharp declines in digital advertising. Morgan Stanley’s valuation comparison shows that earnings multiples have fallen below historical averages, while revenue multiples remain high; stock-based compensation costs also change how valuations look.
Shipments from the Indonesian nickel project rebounded sharply quarter on quarter in the third quarter, but GEM’s net profit for the quarter fell 56% year on year. Morgan Stanley expects pressure from metal prices and sulfur costs to persist in the fourth quarter.
Fares and ancillary revenue pushed Volaris’s quarterly revenue above 1 billion dollars for the first time, and operating profit turned positive. Fourth-quarter margin guidance was below expectations, but after Morgan Stanley adjusted its model to reflect the company’s higher fuel price assumption, the guidance was approximately 21% above its estimate.
